ITK-SYK gene fusion could potentially differentiate a subset of PTCL-NOS patients with TFH phenotype from those with AITL (30, 31, 80, 81) (Figure 1). This evidence concerns the gene SYK and mature T-cell and NK-cell non-Hodgkin lymphoma.